162 related articles for article (PubMed ID: 7726523)
1. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin.
Child J; Andrews JM; Wise R
Antimicrob Agents Chemother; 1995 Feb; 39(2):513-5. PubMed ID: 7726523
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
Johnson JH; Cooper MA; Andrews JM; Wise R
Antimicrob Agents Chemother; 1992 Nov; 36(11):2444-6. PubMed ID: 1336947
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
Wise R; Mortiboy D; Child J; Andrews JM
Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of grepafloxacin.
Efthymiopoulos C
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
Wise R; Jones S; Das I; Andrews JM
Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799
[TBL] [Abstract][Full Text] [Related]
7. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
Efthymiopoulos C; Bramer SL; Maroli A; Flaherty JF; Wolfe E; Bass N; Somberg K
Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
9. Effect of age and gender on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
[TBL] [Abstract][Full Text] [Related]
10. Theophylline and warfarin interaction studies with grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A; Blum B
Clin Pharmacokinet; 1997; 33 Suppl 1():39-46. PubMed ID: 9433655
[TBL] [Abstract][Full Text] [Related]
11. Grepafloxacin.
Wagstaff AJ; Balfour JA
Drugs; 1997 May; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
Kozawa O; Uematsu T; Matsuno H; Niwa M; Nagashima S; Kanamaru M
Antimicrob Agents Chemother; 1996 Dec; 40(12):2824-8. PubMed ID: 9124849
[TBL] [Abstract][Full Text] [Related]
13. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
Wise R; Andrews JM; Ashby JP; Marshall J
J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
Webberley JM; Andrews JM; Ashby JP; McLeod A; Wise R
Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
[TBL] [Abstract][Full Text] [Related]
16. Effect of food and gastric pH on the bioavailability of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():18-24. PubMed ID: 9433652
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
[TBL] [Abstract][Full Text] [Related]
19. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A; Gambertoglio JG
Clin Pharmacokinet; 1997; 33 Suppl 1():32-8. PubMed ID: 9433654
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
